The 2023 Event Has Run: Thank You to Our Speakers, Sponsors and Delegates for Joining Us at the Meeting!

The inaugural Spatial Biology for Immuno-Oncology Summit runs at a crucial moment in time. Spurred on by technological advancement and successful case studies, spatial technologies are set to become increasingly mainstream and accessible. If you’re not already, now is the time to harness spatial technologies to power your immunotherapy research, improve your clinical trials, enhance your biomarker discovery, and streamline your therapeutic development.

Uniting researchers, technology providers, and drug developers, next January join your peers to hear the latest best-practice case studies on operationalizing technology, integrating spatial into the clinic, and developing a robust data analysis pipeline. This meeting will provide an unrivaled opportunity to solve your current spatial challenges to improve your ability to treat disease and identify drug targets in immuno-oncology.

Across 3 jam-packed days of content, led by 20+ immuno-oncology leaders, the Spatial Biology for Immuno-Oncology Summit is your only chance to discover how technologies that put omics and single-cell information in spatial context can improve your ability to treat disease and identify drug targets in immuno-oncology.

Join over 100 key industry stakeholders as they gather and leave no stone unturned to advance the application of this revolutionary technology.

Our 2023 Speaker Faculty

Aarti Tarkar PhD/MBA

Associate Director, Experimental Medicine Unit

GlaxoSmithKline

Carl Barrett

Vice President, Translational Science, Oncology

AstraZeneca

Francesca Ciccarelli

Principal Group Leader

The Francis Crick Institute

Lauri Diehl

Executive Director, Research Pathology

Gilead

Suzana Couto

Vice President, Head of Pathology

Genmab

Tyler Risom

Senior Scientist, Research Pathology

Genentech

What Our Customers Say About Our Events

2560px-Eurofins_Scientific_Logo

"A great meeting with highly ambitious and thoughtful
individuals working towards a unified goal"

“It was a good opportunity to see the latest updates
from industry and academic labs”

obsidian-therapeutics-logo
astrazeneca

“Great event - high caliber talks in a brilliant venue. The event was just the right size and level of informality for networking and making new connections without being overwhelming”